DCs, which load myeloma cell-derived ApoBs, can induce myeloma-specific T cells, leading to the activation of myeloma-reactive allogeneic T lymphocytes that produce IFN-γ [101]. The gene discussed is IFNG; the disease is plasma cell myeloma.